NFKB1 and colonic neoplasm: We noticed that the ruthenium-phloretin complex treatment module effectively decreased NF-κB intensity in the colon carcinoma cells (Figure 5(e), A–G), hence denoting that ruthenium-phloretin treatment influences the inflammatory pathways in colon cancer.